Press "Enter" to skip to content

New patent for Genentech Inc drug ESBRIET

0
Copyright © DrugPatentWatch. Originally published at New patent for Genentech Inc drug ESBRIET

Annual Drug Patent Expirations for ESBRIET
Annual Drug Patent Expirations for ESBRIET

Esbriet is a drug marketed by Genentech Inc and is included in two NDAs. It is available from two suppliers. There are twenty patents protecting this drug and two Paragraph IV challenges.

Drug patent litigation for ESBRIET.

This drug has two hundred and fourteen patent family members in forty-one countries.

The generic ingredient in ESBRIET is pirfenidone. Two suppliers are listed for this compound. Additional details are available on the pirfenidone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Genentech Inc drug ESBRIET
    Do NOT follow this link or you will be banned from the site!